outsourcing facilities association semaglutide lawsuit fda Drug compounders sue US over removal of Wegovy, Ozempic from shortage list FDA Warns on Certain Forms

Pharmaceutical companies are investing in new formulations, including oral and long-acting options, as the market awaits decisions on broader reimbursement for obesity treatment and strategies to improve access

Measuring what matters: Why and how to include patient reported outcomes in clinical care and research on inborn errors of metabolism

L-Carnitine and acetyl-L-carnitine roles and neuroprotection in developing brain

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and diabetes drugs for cash-paying patients

We thank the members of the VK laboratory